News >

Treatment Options Expanding for Benign Hematologic Disorders

Brandon Scalea
Published: Tuesday, Apr 30, 2019

Nathan T. Connell, MD, MPH

Nathan T. Connell, MD, MPH

The addition of eltrombopag (Promacta) has expanded the treatment armamentarium for patients with benign hematologic disorders such as severe aplastic anemia and immune thrombocytopenia (ITP), said Nathan T. Connell, MD, MPH.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Medical Crossfire®: Personalizing Care for Multiple Myeloma Patients: Current and Future Sequencing StrategiesMay 31, 20191.5
Publication Bottom Border
Border Publication